HIV and other highly pathogenic viruses: [ICN Pharmaceuticals Annual Conference on Virology, Newport Beach, Calif., January 15 - 16, 1987]
Gespeichert in:
| Weitere Verfasser: | |
|---|---|
| Format: | Tagungsbericht Buch |
| Sprache: | English |
| Veröffentlicht: |
San Diego [u.a.]
Acad. Press
1988
|
| Schlagworte: | |
| Beschreibung: | IX, 135 S. |
| ISBN: | 0126522456 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV002644192 | ||
| 003 | DE-604 | ||
| 005 | 20120224 | ||
| 007 | t | ||
| 008 | 900517s1988 |||| 10||| engod | ||
| 020 | |a 0126522456 |9 0-12-652245-6 | ||
| 035 | |a (OCoLC)16985506 | ||
| 035 | |a (DE-599)BVBBV002644192 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-188 | ||
| 050 | 0 | |a RC607.A26 | |
| 082 | 0 | |a 616.9/792 |2 19 | |
| 245 | 1 | 0 | |a HIV and other highly pathogenic viruses |b [ICN Pharmaceuticals Annual Conference on Virology, Newport Beach, Calif., January 15 - 16, 1987] |c ed. by Roberts A. Smith |
| 264 | 1 | |a San Diego [u.a.] |b Acad. Press |c 1988 | |
| 300 | |a IX, 135 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 2 | |a Interféron Type I - Usage thérapeutique - Congrès | |
| 650 | 4 | |a Maladies à virus lents - Congrès | |
| 650 | 4 | |a Médicaments contre le sida - Congrès | |
| 650 | 2 | |a Ribonucléoside - Usage thérapeutique - Congrès | |
| 650 | 2 | |a Sida - Thérapeutique - Congrès | |
| 650 | 2 | |a Thymidine - Analogues et dérivés - Congrès | |
| 650 | 2 | |a Virus Maedi Visna - Congrès | |
| 650 | 4 | |a Virus du sida - Congrès | |
| 650 | 4 | |a AIDS (Disease) |x Chemotherapy |v Congresses | |
| 650 | 4 | |a Acquired Immunodeficiency Syndrome |x therapy |v Congresses | |
| 650 | 4 | |a HIV (Viruses) |v Congresses | |
| 650 | 4 | |a HIV |v Congresses | |
| 650 | 4 | |a Interferon Type I |x therapeutic use |v Congresses | |
| 650 | 4 | |a Ribavirin |v Congresses | |
| 650 | 4 | |a Ribonucleosides |x therapeutic use |v Congresses | |
| 650 | 4 | |a Slow virus diseases |v Congresses | |
| 650 | 4 | |a Thymidine |x analogs & derivatives |v Congresses | |
| 650 | 4 | |a Visna-Maedi virus |v Congresses | |
| 650 | 0 | 7 | |a Visna |0 (DE-588)4254508-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmakotherapie |0 (DE-588)4076066-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Aids |0 (DE-588)4112470-4 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1987 |z Newport Beach Calif. |2 gnd-content | |
| 689 | 0 | 0 | |a Aids |0 (DE-588)4112470-4 |D s |
| 689 | 0 | 1 | |a Pharmakotherapie |0 (DE-588)4076066-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Visna |0 (DE-588)4254508-0 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Smith, Roberts A. |4 edt | |
| 710 | 2 | |a ICN Pharmaceuticals (Cincinnati, Ohio) |e Sonstige |0 (DE-588)1040267-6 |4 oth | |
| 711 | 2 | |a Conference on Virology |d 1987 |c Newport Beach, Calif. |j Sonstige |0 (DE-588)819889-5 |4 oth | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-001696687 | ||
Datensatz im Suchindex
| _version_ | 1804117024309248000 |
|---|---|
| any_adam_object | |
| author2 | Smith, Roberts A. |
| author2_role | edt |
| author2_variant | r a s ra ras |
| author_facet | Smith, Roberts A. |
| building | Verbundindex |
| bvnumber | BV002644192 |
| callnumber-first | R - Medicine |
| callnumber-label | RC607 |
| callnumber-raw | RC607.A26 |
| callnumber-search | RC607.A26 |
| callnumber-sort | RC 3607 A26 |
| callnumber-subject | RC - Internal Medicine |
| ctrlnum | (OCoLC)16985506 (DE-599)BVBBV002644192 |
| dewey-full | 616.9/792 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.9/792 |
| dewey-search | 616.9/792 |
| dewey-sort | 3616.9 3792 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Conference Proceeding Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02470nam a2200625 c 4500</leader><controlfield tag="001">BV002644192</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20120224 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">900517s1988 |||| 10||| engod</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0126522456</subfield><subfield code="9">0-12-652245-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)16985506</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV002644192</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-188</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC607.A26</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.9/792</subfield><subfield code="2">19</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">HIV and other highly pathogenic viruses</subfield><subfield code="b">[ICN Pharmaceuticals Annual Conference on Virology, Newport Beach, Calif., January 15 - 16, 1987]</subfield><subfield code="c">ed. by Roberts A. Smith</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">San Diego [u.a.]</subfield><subfield code="b">Acad. Press</subfield><subfield code="c">1988</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">IX, 135 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Interféron Type I - Usage thérapeutique - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Maladies à virus lents - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Médicaments contre le sida - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Ribonucléoside - Usage thérapeutique - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Sida - Thérapeutique - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Thymidine - Analogues et dérivés - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Virus Maedi Visna - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Virus du sida - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">AIDS (Disease)</subfield><subfield code="x">Chemotherapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Acquired Immunodeficiency Syndrome</subfield><subfield code="x">therapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">HIV (Viruses)</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">HIV</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Interferon Type I</subfield><subfield code="x">therapeutic use</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ribavirin</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ribonucleosides</subfield><subfield code="x">therapeutic use</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Slow virus diseases</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Thymidine</subfield><subfield code="x">analogs & derivatives</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Visna-Maedi virus</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Visna</subfield><subfield code="0">(DE-588)4254508-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Aids</subfield><subfield code="0">(DE-588)4112470-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1987</subfield><subfield code="z">Newport Beach Calif.</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Aids</subfield><subfield code="0">(DE-588)4112470-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Visna</subfield><subfield code="0">(DE-588)4254508-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Smith, Roberts A.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">ICN Pharmaceuticals (Cincinnati, Ohio)</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)1040267-6</subfield><subfield code="4">oth</subfield></datafield><datafield tag="711" ind1="2" ind2=" "><subfield code="a">Conference on Virology</subfield><subfield code="d">1987</subfield><subfield code="c">Newport Beach, Calif.</subfield><subfield code="j">Sonstige</subfield><subfield code="0">(DE-588)819889-5</subfield><subfield code="4">oth</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-001696687</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1987 Newport Beach Calif. gnd-content |
| genre_facet | Konferenzschrift 1987 Newport Beach Calif. |
| id | DE-604.BV002644192 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-09T15:47:49Z |
| institution | BVB |
| institution_GND | (DE-588)1040267-6 (DE-588)819889-5 |
| isbn | 0126522456 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-001696687 |
| oclc_num | 16985506 |
| open_access_boolean | |
| owner | DE-12 DE-188 |
| owner_facet | DE-12 DE-188 |
| physical | IX, 135 S. |
| publishDate | 1988 |
| publishDateSearch | 1988 |
| publishDateSort | 1988 |
| publisher | Acad. Press |
| record_format | marc |
| spelling | HIV and other highly pathogenic viruses [ICN Pharmaceuticals Annual Conference on Virology, Newport Beach, Calif., January 15 - 16, 1987] ed. by Roberts A. Smith San Diego [u.a.] Acad. Press 1988 IX, 135 S. txt rdacontent n rdamedia nc rdacarrier Interféron Type I - Usage thérapeutique - Congrès Maladies à virus lents - Congrès Médicaments contre le sida - Congrès Ribonucléoside - Usage thérapeutique - Congrès Sida - Thérapeutique - Congrès Thymidine - Analogues et dérivés - Congrès Virus Maedi Visna - Congrès Virus du sida - Congrès AIDS (Disease) Chemotherapy Congresses Acquired Immunodeficiency Syndrome therapy Congresses HIV (Viruses) Congresses HIV Congresses Interferon Type I therapeutic use Congresses Ribavirin Congresses Ribonucleosides therapeutic use Congresses Slow virus diseases Congresses Thymidine analogs & derivatives Congresses Visna-Maedi virus Congresses Visna (DE-588)4254508-0 gnd rswk-swf Pharmakotherapie (DE-588)4076066-2 gnd rswk-swf Aids (DE-588)4112470-4 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1987 Newport Beach Calif. gnd-content Aids (DE-588)4112470-4 s Pharmakotherapie (DE-588)4076066-2 s DE-604 Visna (DE-588)4254508-0 s Smith, Roberts A. edt ICN Pharmaceuticals (Cincinnati, Ohio) Sonstige (DE-588)1040267-6 oth Conference on Virology 1987 Newport Beach, Calif. Sonstige (DE-588)819889-5 oth |
| spellingShingle | HIV and other highly pathogenic viruses [ICN Pharmaceuticals Annual Conference on Virology, Newport Beach, Calif., January 15 - 16, 1987] Interféron Type I - Usage thérapeutique - Congrès Maladies à virus lents - Congrès Médicaments contre le sida - Congrès Ribonucléoside - Usage thérapeutique - Congrès Sida - Thérapeutique - Congrès Thymidine - Analogues et dérivés - Congrès Virus Maedi Visna - Congrès Virus du sida - Congrès AIDS (Disease) Chemotherapy Congresses Acquired Immunodeficiency Syndrome therapy Congresses HIV (Viruses) Congresses HIV Congresses Interferon Type I therapeutic use Congresses Ribavirin Congresses Ribonucleosides therapeutic use Congresses Slow virus diseases Congresses Thymidine analogs & derivatives Congresses Visna-Maedi virus Congresses Visna (DE-588)4254508-0 gnd Pharmakotherapie (DE-588)4076066-2 gnd Aids (DE-588)4112470-4 gnd |
| subject_GND | (DE-588)4254508-0 (DE-588)4076066-2 (DE-588)4112470-4 (DE-588)1071861417 |
| title | HIV and other highly pathogenic viruses [ICN Pharmaceuticals Annual Conference on Virology, Newport Beach, Calif., January 15 - 16, 1987] |
| title_auth | HIV and other highly pathogenic viruses [ICN Pharmaceuticals Annual Conference on Virology, Newport Beach, Calif., January 15 - 16, 1987] |
| title_exact_search | HIV and other highly pathogenic viruses [ICN Pharmaceuticals Annual Conference on Virology, Newport Beach, Calif., January 15 - 16, 1987] |
| title_full | HIV and other highly pathogenic viruses [ICN Pharmaceuticals Annual Conference on Virology, Newport Beach, Calif., January 15 - 16, 1987] ed. by Roberts A. Smith |
| title_fullStr | HIV and other highly pathogenic viruses [ICN Pharmaceuticals Annual Conference on Virology, Newport Beach, Calif., January 15 - 16, 1987] ed. by Roberts A. Smith |
| title_full_unstemmed | HIV and other highly pathogenic viruses [ICN Pharmaceuticals Annual Conference on Virology, Newport Beach, Calif., January 15 - 16, 1987] ed. by Roberts A. Smith |
| title_short | HIV and other highly pathogenic viruses |
| title_sort | hiv and other highly pathogenic viruses icn pharmaceuticals annual conference on virology newport beach calif january 15 16 1987 |
| title_sub | [ICN Pharmaceuticals Annual Conference on Virology, Newport Beach, Calif., January 15 - 16, 1987] |
| topic | Interféron Type I - Usage thérapeutique - Congrès Maladies à virus lents - Congrès Médicaments contre le sida - Congrès Ribonucléoside - Usage thérapeutique - Congrès Sida - Thérapeutique - Congrès Thymidine - Analogues et dérivés - Congrès Virus Maedi Visna - Congrès Virus du sida - Congrès AIDS (Disease) Chemotherapy Congresses Acquired Immunodeficiency Syndrome therapy Congresses HIV (Viruses) Congresses HIV Congresses Interferon Type I therapeutic use Congresses Ribavirin Congresses Ribonucleosides therapeutic use Congresses Slow virus diseases Congresses Thymidine analogs & derivatives Congresses Visna-Maedi virus Congresses Visna (DE-588)4254508-0 gnd Pharmakotherapie (DE-588)4076066-2 gnd Aids (DE-588)4112470-4 gnd |
| topic_facet | Interféron Type I - Usage thérapeutique - Congrès Maladies à virus lents - Congrès Médicaments contre le sida - Congrès Ribonucléoside - Usage thérapeutique - Congrès Sida - Thérapeutique - Congrès Thymidine - Analogues et dérivés - Congrès Virus Maedi Visna - Congrès Virus du sida - Congrès AIDS (Disease) Chemotherapy Congresses Acquired Immunodeficiency Syndrome therapy Congresses HIV (Viruses) Congresses HIV Congresses Interferon Type I therapeutic use Congresses Ribavirin Congresses Ribonucleosides therapeutic use Congresses Slow virus diseases Congresses Thymidine analogs & derivatives Congresses Visna-Maedi virus Congresses Visna Pharmakotherapie Aids Konferenzschrift 1987 Newport Beach Calif. |
| work_keys_str_mv | AT smithrobertsa hivandotherhighlypathogenicvirusesicnpharmaceuticalsannualconferenceonvirologynewportbeachcalifjanuary15161987 AT icnpharmaceuticalscincinnatiohio hivandotherhighlypathogenicvirusesicnpharmaceuticalsannualconferenceonvirologynewportbeachcalifjanuary15161987 AT conferenceonvirologynewportbeachcalif hivandotherhighlypathogenicvirusesicnpharmaceuticalsannualconferenceonvirologynewportbeachcalifjanuary15161987 |